Precision Optics (POCI) director granted 30,000 stock options
Precision Optics Corporation, Inc. (POCI) reported a new equity award to a director on a Form 4.
Rhea-AI Filing Summary
Precision Optics Corporation, Inc. (POCI) reported a new equity award to a director on a Form 4. The filing shows a grant of stock options to purchase 30,000 shares of common stock at an exercise price of $4.33 per share on 11/17/2025, reported as an acquisition of derivative securities held directly.
The options expire on 11/17/2035 and were granted under the company’s 2022 Equity Incentive Plan. They vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, conditioned on the director’s continuous service with the company through each applicable vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Rights to buy) | 30,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Precision Optics (POCI) report in this Form 4 filing?
How many stock options were granted to the Precision Optics (POCI) director?
What is the exercise price and expiration date of the POCI stock options?
How do the Precision Optics (POCI) director options vest?
Under which plan were the POCI stock options granted?
Is the director’s ownership in POCI reported as direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.